1.
s.l; s.n; 1987. 6 p. ilus.
Non-conventional
in English
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1234499
2.
s.l; s.n; 1985. 16 p. tab, graf.
Non-conventional
in English
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1232134
3.
In. International Leprosy Congress, 12. International Leprosy Congress, 12/Proceedings. New Delhi, s.n, 1984. p.500-502.
Non-conventional
in English
|
LILACS-Express
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1246541
4.
In. International Leprosy Congress, 12. International Leprosy Congress, 12/Proceedings. New Delhi, s.n, 1984. p.506-509, tab.
Non-conventional
in English
|
LILACS-Express
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1246543
5.
Lancet
; 3(801): 457-8, Mar. 3 1973.
Article
in English
| MedCarib
| ID: med-14838
ABSTRACT
A study of serum-samples from immunised individuals showed that administration of yellow-fever and cholera vaccine, simultaneously or one to three weeks apart, reduced the vibriocidal and yellow-fever-virus-neutralising antibody titres (AU)
Subject(s)
Humans , Cholera/prevention & control , Cholera Vaccines/administration & dosage , Viral Vaccines/administration & dosage , Yellow Fever/prevention & control , Antibodies/analysis , Antibody Formation/drug effects , Cholera/immunology , Time Factors , Vaccination , Vibrio cholerae/immunology , Yellow Fever/immunology , Yellow fever virus/immunology
6.
In. Chatterjee, B. R. Leprosy: etiobiology of manifestations treatment and control. s.l, s.n, s.d. p.554-568, ilus, tab, graf.
Monography
in English
|
LILACS-Express
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1246301